Dr.Reddys Laboratories reported 18.98B in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Aspen Pharmacare APN:SJ 9.99B 544M
Bharat Petroleum BPCL:IN 905.27B 63.71B
Cipla CIPLA:IN 21.47B 33.3M
Dr.Reddys Laboratories DRRD:IN 18.98B 831M
Reliance Infra RELI:IN IR 1450090M 188400M
Sun Pharmaceuticals SUNP:IN IR 25396.3M 1009.9M
UPL UPLL:IN 79.94B 28.4B